October 26, 2016 2:15 PM ET

Healthcare Providers and Services

Company Overview of University Hospitals Cleveland Medical Center Inc.

Company Overview

University Hospitals Cleveland Medical Center Inc., doing business as University Hospitals Case Medical Center, owns and operates a tertiary medical center specializing in adult/pediatric medical and surgical specialties. Its services include cancer care, digestive health care, heart and vascular care, neurology and neurosurgery, obstetrics and gynecology, ophthalmology and dermatology, orthopedics and spine, otolaryngology, pediatrics, surgery, transplant, and urology. The company also provides services in the areas of women’s health, radiology and radiation oncology, cardiology and cardiothoracic surgery, organ transplantation and infectious diseases, behavioral health, and human genetics ...

11100 Euclid Avenue

Cleveland, OH 44106

United States

Founded in 1866





Key Executives for University Hospitals Cleveland Medical Center Inc.

Chief Executive Officer
Age: 61
President and Chief of Cardiovascular Medicine
Chief Operating Officer
President of The UH Seidman Cancer Center
Chairman of the Department of Pediatrics at Rainbow Babies & Children's Hospital
Compensation as of Fiscal Year 2016.

University Hospitals Cleveland Medical Center Inc. Key Developments

UH Case Medical Center has Changed its Name to University Hospitals Cleveland Medical Center Inc

UH Case Medical Center changed its name to University Hospitals Cleveland Medical Center Inc.

University Hospitals Case Medical Center First to Implant Abbott Absorb Stent

University Hospitals Case Medical Center to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional metallic predecessors in that it opens a blocked coronary artery, with one major exception it dissolves completely in the body two to three years after implantation. University Hospitals (UH) implanted its first Absorb dissolving stent on a patient with coronary artery disease. Recently approved by the FDA, Absorb is the first and only fully dissolving stent approved for the treatment of coronary artery disease which impacts over 15 million people in the United States and is the cause of death. Made of naturally dissolving material, the new device provides the same benefits as traditional stents and trial data supports its potential benefits in restoring long-term vessel function. The stent utilizes the same cath lab equipment already in place and study data supports comparable healing with the traditional metallic stent. While it may never totally replace traditional DES, this novel technology gives the ability to repair a patient's artery with comparable healing and safety and reduces long-term complications. Like traditional metallic drug-eluding stents (DES), Absorb opens a patient's blocked artery but then disappears after leaving no metal behind to restrict natural vessel motion. Absorb is made of polyactic acid similar to material used in dissolving sutures. Through the process of hydrolysis, the scaffold is metabolized after two to three years. In clinical studies conducted throughout the world, the new Absorb stent demonstrated comparable short-term and mid-term outcomes compared to the metallic stent. After the first year of the clinical trial of approximately 2,000 patients in the United States (Absorb III randomized trial) patients who received the Absorb experienced comparable rates of specific adverse events in the intended patient population. It also eliminates the need for layer upon layer of metal in a situation where patients experience in-stent restenosis. Additionally it reduces the amount of metal in the coronary arteries when the patient requires multiple stents.

University Hospitals Case Medical Center Announces Executive Changes

University Hospitals Case Medical Center has appointed Daniel I. Simon, MD, as the academic medical center's new President effective Jan. 1, 2016. In a release, University Hospitals noted that Dr. Simon will succeed Fred C. Rothstein, MD, who announced his retirement this summer after serving as President of UH Case Medical Center. University Hospitals reported that Dr. Simon is a leader in the field of cardiology. He has enhanced the prominence of UH Harrington Heart & Vascular Institute, where he has served as Director since 2006 and as President since 2014.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University Hospitals Cleveland Medical Center Inc., please visit www.uhhospitals.org/case. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.